Rapid urine test for early-stage bladder cancer

Simple to use, the rapid BladderChek test can be performed outside the laboratory, with reliable results available during a single patient visit in just 30 minutes. Requiring only four drops of urine, the test is unaffected by the presence of blood in the sample, which is commonly seen as one of the first symptoms of bladder cancer. The painless and non-invasive assay makes the NMP22 BladderChek test and NMP22 test kit ideal for initial assessment as well as for monitoring a patient’s condition.

The test detects elevated levels of nuclear matrix protein (NMP22), which are present in the urine of most individuals who have bladder cancer and are detectable even in the early stages of the disease, making it an ideal marker for early diagnosis.

Inverness Medical
www.invernessmedical.com